Your browser doesn't support javascript.
loading
Reconstruction of bone defects around the ankle with retrograde gentamicin-coated tibial intramedullary nail (ETN PROtect™) for tibiotalocalcaneal arthrodesis: a case series.
Zuluaga-Botero, Mauricio; Torres, Daniel; Medina-García, Juan Camilo; Benedetti, Fernando.
Afiliação
  • Zuluaga-Botero M; Limb of Lengthening and Reconstruction Unit, Clínica Imbanaco Grupo QuirónSalud, Carrera 38A #5ª-100, Tower A, Office 803, Cali, Colombia. Mauricio.Zuluaga@quironsalud.com.
  • Torres D; Faculty of Health Sciences, Pontificia Universidad Javeriana Cali, Cali, Colombia. Mauricio.Zuluaga@quironsalud.com.
  • Medina-García JC; Department of Orthopedics and Traumatology - TRAUMATOR Research Group, Universidad del Valle, Cali, Colombia. Mauricio.Zuluaga@quironsalud.com.
  • Benedetti F; Limb of Lengthening and Reconstruction Unit, Clínica Imbanaco Grupo QuirónSalud, Carrera 38A #5ª-100, Tower A, Office 803, Cali, Colombia.
Eur J Orthop Surg Traumatol ; 34(7): 3789-3795, 2024 Oct.
Article em En | MEDLINE | ID: mdl-39352525
ABSTRACT

PURPOSE:

The objective of this study was to describe the use of retrograde gentamicin-coated tibial intramedullary nail (ETN PROtect™) in patients with tibial defects who required a tibiotalocalcaneal arthrodesis (TTC).

METHODS:

Consecutive series case review of seven men treated with TTC using retrograde PROtect™ between January 2018 and December 2023. The main outcomes evaluated were fracture union, complications, and the health-related quality of life using the EuroQol five-dimension three-level questionnaire (EQ-5D-3L).

RESULTS:

The mean age was 45.3 ± 8.0 years. Six patients had a clinical history of chronic osteomyelitis, and one case underwent TTC for congenital pseudoarthrosis. Fracture union was achieved in 5 of 7 patients between 4 and 11 months after surgery. Three patients developed complications; two patients had fistulas, and one had persistent pain. At the end of the follow-up, a median of 70 points (interquartile range 60 to 90) on the EQ-5D-3L was reported. No complications directly attributed to the use of the PROtect™ were reported.

CONCLUSION:

TTC with retrograde PROtect™ is a prophylactic treatment option in patients with tibial defects treated with external fixation requiring a tibiotalar and subtalar arthrodesis. This novel use of PROtect™ allows simultaneous fixation of the tibiotalocalcaneal joint and protection of the regenerated bone, facilitating earlier rehabilitation in patients at high risk for postoperative infections.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteomielite / Artrodese / Tíbia / Pinos Ortopédicos / Gentamicinas Limite: Adult / Humans / Male / Middle aged Idioma: En Revista: Eur J Orthop Surg Traumatol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Colômbia País de publicação: França
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteomielite / Artrodese / Tíbia / Pinos Ortopédicos / Gentamicinas Limite: Adult / Humans / Male / Middle aged Idioma: En Revista: Eur J Orthop Surg Traumatol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Colômbia País de publicação: França